Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters
When Gilead Sciences picked up Immunomedics and the br---t cancer dr-g Trodelvy for $21 billion a couple years back, the company billed the buyout as a major expansion into oncology. Now, the California-based dr-gmaker is laying off more than 100 staffers based out of the former Immunomedics headquarters as it gears up for change in New Jersey.
https://www.fiercepharma.com/pharma/gilead-sciences-laying-114-staffers-former-immunomedics-headquarters